“Lycorine inhibits MDA-MB-231 breast cancer cell proliferation, migration and invasion that are associated with Wnt/β-catenin signaling” (2018) Bangladesh Journal of Pharmacology, 13(2), pp. 192–195. doi:10.3329/bjp.v13i2.36350.